You are here:Home-Chemical Inhibitors & Agonists-Antibiotics and Antivirals-HBV-Nitazoxanide
Nitazoxanide

Chemical Structure : Nitazoxanide

CAS No.: 55981-09-4

Nitazoxanide

Catalog No.: PC-49553Not For Human Use, Lab Use Only.

Nitazoxanide (NTX) is a thiazolide anti-infective agent that efficiently inhibits the HBV regulatory protein X (HBx)-DDB1 protein interaction, exhibits potent inhibition of both HBV and HCV replication.

Packing Price Stock Quantity
100 mg $188 In stock
500 mg $358 In stock
1 g $588 In stock
5 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Nitazoxanide (NTX) is a thiazolide anti-infective agent that efficiently inhibits the HBV regulatory protein X (HBx)-DDB1 protein interaction, exhibits potent inhibition of both HBV and HCV replication.
Nitazoxanide significantly restores Smc5 protein levels and suppresses viral transcription and viral protein production in the HBV minicircle system and in human primary hepatocytes naturally infected with HBV.
Nitazoxanide is active against anaerobic bacteria, protozoa, and a range of viruses in cell culture model.
Nitazoxanide is equally effective at inhibiting replication of lamivudine (LMV) and adefovir dipovoxil (ADV)-resistant HBV mutants and against 2'-C-methyl cytidine (2'CmeC) and telaprevir (VX-950)-resistant HCV mutants.
Nitazoxanide displayed synergistic interactions with LMV or ADV against HBV, and with recombinant interferon alpha-2b (IFN) or 2'CmeC against HCV.

Physicochemical Properties

M.Wt 307.28
Formula C12H9N3O5S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-benzamide

References

1. Korba BE, et al. Antiviral Res. 2008 Jan;77(1):56-63.

2. Keeffe EB, et al. World J Gastroenterol. 2009 Apr 21;15(15):1805-8.

3. Sekiba K, et al. Cell Mol Gastroenterol Hepatol. 2019;7(2):297-312.

4. Sekiba K, et al. J Hepatol. 2022 Jan;76(1):53-62.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: